1. Home
  2. MPTI vs MAIA Comparison

MPTI vs MAIA Comparison

Compare MPTI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M-tron Industries Inc.

MPTI

M-tron Industries Inc.

HOLD

Current Price

$88.38

Market Cap

392.9M

Sector

N/A

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.36

Market Cap

77.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPTI
MAIA
Founded
1965
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.9M
77.1M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
MPTI
MAIA
Price
$88.38
$1.36
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$71.00
N/A
AVG Volume (30 Days)
59.3K
851.6K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
0.67
N/A
Revenue
$54,417,000.00
N/A
Revenue This Year
$11.06
N/A
Revenue Next Year
$12.15
N/A
P/E Ratio
$137.99
N/A
Revenue Growth
11.03
N/A
52 Week Low
$36.38
$0.87
52 Week High
$93.78
$3.19

Technical Indicators

Market Signals
Indicator
MPTI
MAIA
Relative Strength Index (RSI) 62.90 51.18
Support Level $60.13 $1.21
Resistance Level N/A $1.46
Average True Range (ATR) 4.35 0.10
MACD 0.38 0.02
Stochastic Oscillator 67.27 41.18

Price Performance

Historical Comparison
MPTI
MAIA

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is an electronic components manufacturer based in the United States. Along with its subsidiaries, the company is engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company serves markets in aerospace and defense, space, and avionics sectors. Its product offerings include microwave and millimeter-wave filters, crystal resonators, clock oscillators, voltage-controlled crystal oscillators, low noise amplifiers, couplers, attenuators, and switches, among others. Geographically, it derives maximum revenue from the domestic market, and the rest from Malaysia, Australia, Greece, and other countries.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: